Table S1. Correlation of OS with clinical characteristics.
| Items | Mean OS (95% CI) (months) | P value |
|---|---|---|
| Age, years | 0.828 | |
| <60 | 8.2 (4.7–11.8) | |
| ≥60 | 14.2 (10.4–18.1) | |
| Gender | 0.652 | |
| Female | 10.5 (6.9–14.0) | |
| Male | 14.8 (10.3–19.3) | |
| History of smoke | 0.906 | |
| No | 11.8 (8.1–15.5) | |
| Yes | 14.0 (9.2–18.7) | |
| Tumor location | 0.461 | |
| Left | 15.4 (9.6–21.2) | |
| Right | 11.6 (8.2–15.0) | |
| Tumor size, cm | 0.023 | |
| ≤5 | 19.0 (12.5–25.5) | |
| >5 | 10.4 (7.3–13.6) | |
| Histologic type | 0.051 | |
| Squamous cell carcinoma | 9.0 (5.6–12.4) | |
| Adenocarcinoma | 17.4 (11.5–23.4) | |
| Mixed carcinoma | 12.0 (0.7–23.4) | |
| Pathological differentiation | 0.146 | |
| Moderate | – | |
| Poor | – | |
| ECOG score | 0.094 | |
| 0 | 7.7 (5.5–10.0) | |
| 1/2 | 15.6 (11.4–19.7) | |
| Previous chemotherapy | 0.224 | |
| No | 16.3 (10.4–22.3) | |
| Yes | 11.0 (6.3–15.6) | |
| Previous targeted therapy | 0.453 | |
| No | 15.2 (10.9–19.4) | |
| Yes | 12.0 (10.9–13.2) |
Correlation was determined by Log-rank test. OS, overall survival; ECOG, Eastern Cooperative Oncology Group; NSCLC, non-small cell lung cancer; 125I, iodine-125.